Logo image of ART.MI

DEODATO GALLERY SPA (ART.MI) Stock Fundamental Analysis

BIT:ART - IT0005528937 - Common Stock

0.36 EUR
+0.02 (+5.26%)
Last: 8/25/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ART. ART was compared to 58 industry peers in the Hotels, Restaurants & Leisure industry. While ART seems to be doing ok healthwise, there are quite some concerns on its profitability. ART is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ART has reported negative net income.
In the past year ART had a positive cash flow from operations.
ART.MI Yearly Net Income VS EBIT VS OCF VS FCFART.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M -1M -2M

1.2 Ratios

ART's Return On Assets of 1.05% is in line compared to the rest of the industry. ART outperforms 44.83% of its industry peers.
With a Return On Equity value of 2.35%, ART perfoms like the industry average, outperforming 53.45% of the companies in the same industry.
ART has a Return On Invested Capital (3.16%) which is comparable to the rest of the industry.
ART had an Average Return On Invested Capital over the past 3 years of 13.79%. This is in line with the industry average of 12.02%.
The 3 year average ROIC (13.79%) for ART is well above the current ROIC(3.16%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.05%
ROE 2.35%
ROIC 3.16%
ROA(3y)6.18%
ROA(5y)N/A
ROE(3y)16.81%
ROE(5y)N/A
ROIC(3y)13.79%
ROIC(5y)N/A
ART.MI Yearly ROA, ROE, ROICART.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 20 40 60

1.3 Margins

ART has a Profit Margin of 1.24%. This is comparable to the rest of the industry: ART outperforms 44.83% of its industry peers.
In the last couple of years the Profit Margin of ART has declined.
ART has a worse Operating Margin (2.74%) than 60.34% of its industry peers.
In the last couple of years the Operating Margin of ART has declined.
ART has a Gross Margin of 25.49%. This is in the lower half of the industry: ART underperforms 63.79% of its industry peers.
In the last couple of years the Gross Margin of ART has declined.
Industry RankSector Rank
OM 2.74%
PM (TTM) 1.24%
GM 25.49%
OM growth 3Y-50.63%
OM growth 5YN/A
PM growth 3Y-57.05%
PM growth 5YN/A
GM growth 3Y-9.55%
GM growth 5YN/A
ART.MI Yearly Profit, Operating, Gross MarginsART.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ART is creating value.
Compared to 1 year ago, ART has about the same amount of shares outstanding.
The debt/assets ratio for ART is higher compared to a year ago.
ART.MI Yearly Shares OutstandingART.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
ART.MI Yearly Total Debt VS Total AssetsART.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

ART has an Altman-Z score of 2.92. This is not the best score and indicates that ART is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.92, ART is in the better half of the industry, outperforming 72.41% of the companies in the same industry.
The Debt to FCF ratio of ART is 12.11, which is on the high side as it means it would take ART, 12.11 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ART (12.11) is worse than 60.34% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that ART is not too dependend on debt financing.
ART has a Debt to Equity ratio of 0.12. This is amongst the best in the industry. ART outperforms 84.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 12.11
Altman-Z 2.92
ROIC/WACC0.42
WACC7.5%
ART.MI Yearly LT Debt VS Equity VS FCFART.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

ART has a Current Ratio of 1.96. This is a normal value and indicates that ART is financially healthy and should not expect problems in meeting its short term obligations.
ART's Current ratio of 1.96 is amongst the best of the industry. ART outperforms 96.55% of its industry peers.
ART has a Quick Ratio of 1.06. This is a normal value and indicates that ART is financially healthy and should not expect problems in meeting its short term obligations.
ART's Quick ratio of 1.06 is fine compared to the rest of the industry. ART outperforms 67.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.06
ART.MI Yearly Current Assets VS Current LiabilitesART.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 400.00% over the past year.
ART shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -50.75% yearly.
Looking at the last year, ART shows a very negative growth in Revenue. The Revenue has decreased by -14.67% in the last year.
Measured over the past years, ART shows a quite strong growth in Revenue. The Revenue has been growing by 14.70% on average per year.
EPS 1Y (TTM)400%
EPS 3Y-50.75%
EPS 5YN/A
EPS Q2Q%81.67%
Revenue 1Y (TTM)-14.67%
Revenue growth 3Y14.7%
Revenue growth 5YN/A
Sales Q2Q%-23.07%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ART.MI Yearly Revenue VS EstimatesART.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2M 4M 6M 8M 10M

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
ART.MI Price Earnings VS Forward Price EarningsART.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

ART's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, ART is valued a bit more expensive than the industry average as 68.97% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 66.27
EV/EBITDA 19.01
ART.MI Per share dataART.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.05 0.1 0.15 0.2 0.25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ART!.
Industry RankSector Rank
Dividend Yield N/A

DEODATO GALLERY SPA

BIT:ART (8/25/2025, 7:00:00 PM)

0.36

+0.02 (+5.26%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.19%
Inst Owner ChangeN/A
Ins Owners83.3%
Ins Owner ChangeN/A
Market Cap11.28M
Analysts80
Price Target0.87 (141.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.27
P/FCF 66.27
P/OCF 32.01
P/B 2.41
P/tB 3.04
EV/EBITDA 19.01
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY1.51%
OCF(TTM)0.01
OCFY3.12%
SpS0.28
BVpS0.15
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.05%
ROE 2.35%
ROCE 4.21%
ROIC 3.16%
ROICexc 4.55%
ROICexgc 5.99%
OM 2.74%
PM (TTM) 1.24%
GM 25.49%
FCFM 1.92%
ROA(3y)6.18%
ROA(5y)N/A
ROE(3y)16.81%
ROE(5y)N/A
ROIC(3y)13.79%
ROIC(5y)N/A
ROICexc(3y)18.08%
ROICexc(5y)N/A
ROICexgc(3y)22.97%
ROICexgc(5y)N/A
ROCE(3y)18.39%
ROCE(5y)N/A
ROICexcg growth 3Y-56.79%
ROICexcg growth 5YN/A
ROICexc growth 3Y-59.09%
ROICexc growth 5YN/A
OM growth 3Y-50.63%
OM growth 5YN/A
PM growth 3Y-57.05%
PM growth 5YN/A
GM growth 3Y-9.55%
GM growth 5YN/A
F-Score7
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 12.11
Debt/EBITDA 0.95
Cap/Depr 50.07%
Cap/Sales 2.05%
Interest Coverage 250
Cash Conversion 58.02%
Profit Quality 155.29%
Current Ratio 1.96
Quick Ratio 1.06
Altman-Z 2.92
F-Score7
WACC7.5%
ROIC/WACC0.42
Cap/Depr(3y)231.4%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)400%
EPS 3Y-50.75%
EPS 5YN/A
EPS Q2Q%81.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.67%
Revenue growth 3Y14.7%
Revenue growth 5YN/A
Sales Q2Q%-23.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y76.45%
EBIT growth 3Y-43.38%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y107.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y126.72%
OCF growth 3YN/A
OCF growth 5YN/A